North America Single Cell Analysis Market Size & Outlook
The single cell analysis market in North America is expected to reach a projected revenue of US$ 10,469.0 million by 2033. A compound annual growth rate of 21.13% is expected of North America single cell analysis market from 2026 to 2033.
In terms of revenue, North America region accounted for 42.5% of the global single cell analysis market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 4,101.4 million by 2033.
North America's single-cell analysis market is expected to grow at a lucrative rate owing to an increase in the adoption of genomic medicines, biopharmaceuticals, and novel technologies such as next-generation sequencing in the U.S. and Canada for diagnosing & treating clinical disorders.
For instance, in February 2024, Takara Bio announced the launch of two single-cell solutions, Shasta Total RNA-Seq Kit and Shasta Whole-Genome Amplification Kit. These two novel automated single cell technologies are anticipated to propel oncology-related research.
In addition, the increasing use of genomic, proteomic, and cell biology-based platforms in the region is boosting the uptake of single-cell analysis tools. The easy availability of government funding for research is anticipated to boost the market in this region.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Single Cell Analysis Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 63.66% in 2025.
Horizon Databook has segmented the North America single cell analysis market based on instruments, consumables covering the revenue growth of each sub-segment from 2021 to 2033.
North America's single-cell analysis market is expected to grow at a lucrative rate owing to an increase in the adoption of genomic medicines, biopharmaceuticals, and novel technologies such as next-generation sequencing in the U.S. and Canada for diagnosing & treating clinical disorders.
For instance, in February 2024, Takara Bio announced the launch of two single-cell solutions, Shasta Total RNA-Seq Kit and Shasta Whole-Genome Amplification Kit. These two novel automated single cell technologies are anticipated to propel oncology-related research.
In addition, the increasing use of genomic, proteomic, and cell biology-based platforms in the region is boosting the uptake of single-cell analysis tools. The easy availability of government funding for research is anticipated to boost the market in this region.
North America Single Cell Analysis Market Product Outlook (Revenue, USD Million , 2021-2033)
Consumables
Instruments
North America Single Cell Analysis Market Application Outlook (Revenue, USD Million , 2021-2033)
Cancer
Immunology
Neurology
Stem Cell
Non invasive prenatal diagnosis
In vitro Fertilisation
Other Application
North America Single Cell Analysis Market Workflow Outlook (Revenue, USD Million , 2021-2033)
Single Cell Isolation & Library Preparation
Downstream Analysis
Data Analysis
North America Single Cell Analysis Market End Use Outlook (Revenue, USD Million , 2021-2033)
Academic & Research Laboratories
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Other End Use
Reasons to subscribe to Single Cell Analysis Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Single Cell Analysis Market Outlook databook
Our clientele includes a mix of Single Cell Analysis Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Single Cell Analysis Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Single Cell Analysis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America Single Cell Analysis Market, 2021-2033 (US$M)